CHICAGO, IL / ACCESS Newswire / April 16, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome a leading ...

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. The phase 3 study linked the oral GLP-1 drug orforglipron to similar reductions in blood glucose and body ...

A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a ...

The topline results are from ACHIEVE-1, the first phase III trial of an oral GLP-1 drug to successfully reach completion, a press release notes. Taken as a once-daily pill, orforglipron, unlike oral ...

The Phase 1 trial was a randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple ...

Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, establishing leadership in obesity treatment. Orforglipron offers advantages ...

The state may request prime minister Narendra Modi to inaugurate this stretch on May 1 when he is in Mumbai to inaugurate the World Audio Visual & Entertainment Summit Mumbai: The last phase of ...

We have added it to a list of your favorite stories. Head Start centers across the U.S. have received nearly $1 billion less in federal money compared with this time last year — and a lag in ...

Hardik Pandya was denied a wicket despite dismissing Travis Head twice in two consecutive deliveries during the IPL 2025 encounter between Mumbai Indians and Sunrisers Hyderabad on Thursday.